Skip to main content
logo
Invex Therapeutics Ltd (ASX:IXC)
Australia flag Australia · Delayed Price · Currency is AUD
0.1150
0.00 (0.00%)
Sep 16, 2026, 12:33 PM AEST

Invex Therapeutics Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
-1.35-0.48-1.64-7.75-3.95
Stock-Based Compensation
-0.020.140.480.35
Other Operating Activities
-0.02-0.040.020
Change in Accounts Receivable
-0.05-00.24-0.19-0.12
Change in Accounts Payable
0.04-0.21-1.140.570.35
Operating Cash Flow
-1.36-0.65-2.44-6.87-3.38
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Investment in Securities
-2.5----
Investing Cash Flow
-2.5----

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Repurchase of Common Stock
---14--
Financing Cash Flow
---14--

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Foreign Exchange Rate Adjustments
-0---
Net Cash Flow
-3.86-0.65-16.45-6.87-3.38

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Levered Free Cash Flow
-0.96-0.64-2.1-4.48-1.95
Unlevered Free Cash Flow
-0.96-0.64-2.1-4.48-1.95

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash Income Tax Paid
-0.05-0.23-1.21-0.46-
Change in Working Capital
-0.01-0.21-0.90.380.22